Search the Newsreel

Oregon Public Employees Retirement Fund Boosts Stock Position in Medtronic PLC $MDT

The Oregon Public Employees Retirement Fund increased its stake in Medtronic PLC by 7.6% in the second quarter of 2026, adding 11,167 shares to now hold 157,862 shares valued at $12.35 million. Institutional investors collectively own 82.06% of Medtronic, and analysts have a consensus …

MEDITERA TIBBI MALZEME (MEDTR) Hisse Senedi

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Merit Medical Systems, Inc. $MMSI Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Merit Medical Systems (MMSI) by 200.3% in the first quarter, now owning 17,612 shares valued at approximately $1.21 million. This comes as institutional investors collectively hold 99.66% of the stock, and analysts maintain a "Moderate …

Medtronic PLC $MDT Shares Bought by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, purchasing an additional 11,094 shares, bringing their total to 20,060 shares valued at $1,645,000. Other institutional investors also adjusted their holdings, with the company's stock currently having …

Truth Social Spin-Off Plans Scrapped – DJT Stock Gains After Trump Media Says TAE Merger Completion Remains On Track

Insmed, Inc. $INSM Shares Bought by Empowered Funds LLC

Empowered Funds LLC increased its stake in Insmed, Inc. (NASDAQ:INSM) by 32.6% in the first quarter, owning 51,986 shares worth $8.5 million. Several other institutional investors also increased their holdings in Insmed during the same period, while company insiders made significant stock sales. Analyst …

Viemed Healthcare (NASDAQ:VMD) Lowered to "Buy" Rating by Wall Street Zen

CEO EVENT MEDYA (CEOEM) Hisse Senedi

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …

Wall Street Zen Downgrades MediWound (NASDAQ:MDWD) to Strong Sell

Wall Street Zen has downgraded MediWound (NASDAQ:MDWD) from "sell" to "strong sell," despite the broader analyst consensus being "Hold" with an average price target of $33.00. MediWound's shares opened at $13.56, close to its 12-month low, and the company recently missed quarterly earnings expectations …

SBC Medical Group (NASDAQ:SBC) Stock Rating Upgraded by Wall Street Zen

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen has upgraded Oramed Pharmaceuticals (NASDAQ:ORMP) from a "hold" to a "buy" rating, though MarketBeat's overall analyst rating for the company remains "Hold." Oramed Pharmaceuticals opened at $4.48, with a market capitalization of $186.35 million. The company recently reported a quarterly loss …

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

MediWound (MDWD) reported a Q2 revenue of US$3.1 million and a net loss of US$7.4 million, reflecting a revenue decline but a narrowed loss per share year-over-year. The company's cash burn and reliance on two key assets, EscharEx and NexoBrid, are concerns, despite reaffirming …

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News

The article provides information related to Parabilis Medicines (PBLS) stock options chain, including quotes and news. The content itself is not available in the provided input.

Prime Medicine, Inc. Stock 12‑Month Price Target Cut to $6.92, Implies 124% Upside

The average 12-month price target for Prime Medicine, Inc. (PRME) stock has been lowered from $7.12 to $6.92 by 9 analysts, yet this new target still suggests a significant 124% potential upside from its August 14th closing price. The consensus rating for PRME remains …

InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares

Ikarian Capital, LLC and Neil Shahrestani have jointly reported a 4.2% beneficial ownership stake in InMed Pharmaceuticals Inc. (INM), totaling 137,634 common shares. This ownership, held through Ikarian Healthcare Master Fund, L.P. and separately managed accounts, is based on 3,314,063 common shares outstanding as …

NewMed Energy (TASE:NWMD) Stock Can Strong Gas Growth Justify A 24.4x P E

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …

Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding

Orchestra BioMed Holdings, Inc. director Eric S. Fain reported an indirect disposition of 5,145 common stock shares on August 12, 2026. These shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) and no …

Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares

Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu recently sold 804 shares of the company's stock for $66,442.56, reducing his total holdings by 1.46%. This sale is part of a series of insider transactions since mid-June. Despite these sales, the company exceeded its recent quarterly …

NewMed Energy LP (DKDRF) (Q2 2026) Earnings Call Highlights: Record Production and Strategic ...

This article first appeared on GuruFocus. Revenue: $293 million in Q2 2026, up from $191 million in Q2 2025. Net Profit: $117 million in Q2 2026, compared to $81 million in the same quarter last year. Production: 2.7 bcm in Q2 2026, versus 2 …

Pediatrix Medical Group (MD) awards 472-share equity grant to director

Pediatrix Medical Group (MD) director Shirley A. Weis was granted 472 restricted shares of common stock on August 12, 2026, under the company's 2008 Incentive Compensation Plan. These shares, valued at $26.50 each, will vest on May 7, 2027, and increase Weis's direct holdings …

MiniMed Group Inc. (MMED) Stock Price | Live Quotes & Charts | NASDAQ

Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ

PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress Across VARIS, PortIO, and Lucid

PAVmed Inc. reported significantly narrowed losses in Q2 2026, with a GAAP net loss of $6.6 million compared to $12.3 million in the prior year. The company is advancing the commercial launch of VARIS at Ohio State University, exploring a potentially faster 510(k) regulatory …

CorMedix (CRMD) Stock Drops As Raised Outlook Fails To Soothe Risk Concerns

SBC Medical Group Holdings (SBC) Stock Reprices As Margins Power Profit Surge

Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com

Disc Medicine's COO, Jonathan Yu, sold 804 shares of the company's common stock for a total of $66,444 at an average price of $82.6425. This transaction was part of a pre-arranged trading plan, and it occurred as the stock had seen a 41% return …

Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan

Disc Medicine's COO, Yu Jonathan Yen-Wen, exercised stock options for 804 shares at $13.50 each and simultaneously sold these 804 shares at a weighted average price of $82.6425. These transactions, which generated an approximate pre-tax spread of $56,000, were conducted under a pre-arranged Rule …

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

HCM|HUTCHMED (China) Ltd|Price:12.180|Chg%:+0.020

Trump Media's Stock Fell 54%. Here's What Its Technology Chief's Latest Filing Signals

Vladimir Novachki, the chief technology officer of Trump Media & Technology Group Corp. (NASDAQ:DJT), disposed of 29,957 shares of common stock on August 13, according to a recent SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 29,957 Transaction value $249,542 Post-transaction …

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction

Should You Worry About Trump Media Insider Activity as the Stock Falls? Here's How to Read It

Kevin McGurn, the company's interim CEO, reported the disposition of 16,509 shares of Trump Media & Technology Group Corp. (NASDAQ:DJT) on August 13, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value $137,520 Shares sold 16,509 Post-transaction shares (directly held) …

ResMed Inc. stock falls Friday, underperforms market

ResMed Inc. (RMD) stock decreased by 1.01% to $224.46 on Friday, underperforming the broader market as the S&P 500 and Dow Jones Industrial Average also experienced declines. This fall ended a four-day winning streak for the company's shares.